1Galgiani J N,Rinaldi M C,Polak A M,et al.Standardization of antifungal susceptibility testing[J].J Med Vet Mycol,1992,30(11):213.
2NationaI Committee for Clinical Laboratory Standards.Reference method for brothdilution antifungal susceptibility testing of years[S].Approved standard.NCCLS Document M27-A.Villanova.PA.1997.
3Espinel-Ingroff A,Bartlett M,Bowden R,et al.Comparative and collaborative evaluation of standardized of antifungal susceptibility testing for filamentous fungi[J].Antimicrob Agents Chemother,1995.39:314-319.
4Espinel-Ingroff A,Bartlett M,Bowden R,et al.Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi[J].J Clin Microbiol,1995,35:139-143.
5National Committee for Clinical Laboratory Standards.Reference method for brothdilution antifungal susceptibility testing of conidiumforming filamentousfungi:Proposed standard NCCLS Document M38-P National Committee for Clinical Laboratory Standards[C].Wayne,1998.1-21.
6Petrayi G,Meingassner J G,Mieth H.Antifungal activity of the allylamine derivative terbinafine in vitro[J].Antimicrob Agents Chemother,1987,31:1365.
7Schmitt H J,Bernard E M,Andrade J,et al.MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp[J].Antimicrob Agents Chemother,1998,32:780.
8Rex J H,Pfaller M A,Walsh T J,et al.practival aspects and current challenges[J].Clin Microbiol Rev.2001,14(4):643-658.
9Rex J H,Pfaller M A,Galgiani J N,et al.Development of interpretive breakpoints for antifungal susceptibility testing:conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole,itraconazole,and candida infections.Subcommittee on Antifungal Susceptibility Testion of the National Committee for Clinical Laboratory Standards[J].Clin Infect Dis,1997,24(2):235-247.
